Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MYL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MARK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
XBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HABP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC389906 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100289094 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
MAP2K7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAGE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPX7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORA17B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRTM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLKB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on